4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isothiazole, 97%, 1g

4,4,4-Trifluoro-1-(2,4-dichlorophenyl)-1,3-butanedione, 98%, 1g

5-bromo-1-methyl-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 250mg

Myristonitrile>96.0%(GC)25mL

Cyclopropanecarboxamide, N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-, 98%, 25mg

o-Anisidine hydrochloride, 97.0%, 25g

methyl 3-{[3-(propan-2-yloxy)propyl]amino}butanoate, 95.0%, 10g

2-Methylbenzoic acid, 97.0%, 25g

5-Fluorobenzo[d]oxazole, 95.0%, 25g

3'-chloro-3-(4-fluorophenyl)propiophenone, 97.0%, 1g

2-Amino-4-bromo-5-chlorobenzoic acid, 98.0%, 25g

2-Chloro-4-fluorobenzohydrazide, 95%, 5g

Phenyl tosylate, 99.0%, 10g